Utility of [18F]-fluoroestradiol (FES) PET/CT with dedicated brain acquisition in differentiating brain metastases from posttreatment change in estrogen receptor-positive breast cancer.

Publication Type Academic Article
Authors Ivanidze J, Subramanian K, Youn T, Cigler T, Osborne J, Magge R, Balogun O, Knisely J, Ramakrishna R
Journal Neurooncol Adv
Volume 3
Issue 1
Pagination vdab178
Date Published 11/30/2021
ISSN 2632-2498
DOI 10.1093/noajnl/vdab178
PubMed ID 34988456
PubMed Central ID PMC8713741
Back to Top